The changing face of gastric cancer: epidemiologic trends and advances in novel therapies

Raghav Chandra; Neeraja Balachandar; Sam Wang; Scott Reznik; Herbert Zeh; Matthew Porembka

doi:10.1038/s41417-020-00234-z

The changing face of gastric cancer: epidemiologic trends and advances in novel therapies

Raghav Chandra, Neeraja Balachandar, Sam Wang, Scott Reznik, Herbert Zeh, Matthew Porembka

Research output: Contribution to journal › Review article › peer-review

25 Scopus citations

Abstract

Gastric cancer is an aggressive solid-tumor malignancy with poor prognosis. The epidemiologic face of gastric cancer is changing and further insight into its heterogenous immunohistopathologic nature is needed to develop personalized therapies for specific patient populations. In this review, we highlight changes in gastric cancer epidemiology with a special emphasis on racial and ethnic variations and discuss the implications of current clinical and preclinical treatment advances.

Original language	English (US)
Pages (from-to)	390-399
Number of pages	10
Journal	Cancer Gene Therapy
Volume	28
Issue number	5
DOIs	https://doi.org/10.1038/s41417-020-00234-z
State	Published - May 2021

ASJC Scopus subject areas

Molecular Medicine
Molecular Biology
Cancer Research

Access to Document

10.1038/s41417-020-00234-z

Cite this

@article{b94f993372004c25beba4e055926ce68,

title = "The changing face of gastric cancer: epidemiologic trends and advances in novel therapies",

abstract = "Gastric cancer is an aggressive solid-tumor malignancy with poor prognosis. The epidemiologic face of gastric cancer is changing and further insight into its heterogenous immunohistopathologic nature is needed to develop personalized therapies for specific patient populations. In this review, we highlight changes in gastric cancer epidemiology with a special emphasis on racial and ethnic variations and discuss the implications of current clinical and preclinical treatment advances.",

author = "Raghav Chandra and Neeraja Balachandar and Sam Wang and Scott Reznik and Herbert Zeh and Matthew Porembka",

note = "Publisher Copyright: {\textcopyright} 2020, The Author(s), under exclusive licence to Springer Nature America, Inc.",

year = "2021",

month = may,

doi = "10.1038/s41417-020-00234-z",

language = "English (US)",

volume = "28",

pages = "390--399",

journal = "Cancer Gene Therapy",

issn = "0929-1903",

publisher = "Nature Publishing Group",

number = "5",

}

TY - JOUR

T1 - The changing face of gastric cancer

T2 - epidemiologic trends and advances in novel therapies

AU - Chandra, Raghav

AU - Balachandar, Neeraja

AU - Wang, Sam

AU - Reznik, Scott

AU - Zeh, Herbert

AU - Porembka, Matthew

PY - 2021/5

Y1 - 2021/5

N2 - Gastric cancer is an aggressive solid-tumor malignancy with poor prognosis. The epidemiologic face of gastric cancer is changing and further insight into its heterogenous immunohistopathologic nature is needed to develop personalized therapies for specific patient populations. In this review, we highlight changes in gastric cancer epidemiology with a special emphasis on racial and ethnic variations and discuss the implications of current clinical and preclinical treatment advances.

AB - Gastric cancer is an aggressive solid-tumor malignancy with poor prognosis. The epidemiologic face of gastric cancer is changing and further insight into its heterogenous immunohistopathologic nature is needed to develop personalized therapies for specific patient populations. In this review, we highlight changes in gastric cancer epidemiology with a special emphasis on racial and ethnic variations and discuss the implications of current clinical and preclinical treatment advances.

UR - http://www.scopus.com/inward/record.url?scp=85092011696&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85092011696&partnerID=8YFLogxK

U2 - 10.1038/s41417-020-00234-z

DO - 10.1038/s41417-020-00234-z

M3 - Review article

C2 - 33009508

AN - SCOPUS:85092011696

SN - 0929-1903

VL - 28

SP - 390

EP - 399

JO - Cancer Gene Therapy

JF - Cancer Gene Therapy

IS - 5

ER -

The changing face of gastric cancer: epidemiologic trends and advances in novel therapies

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this